Found: 34
Select item for more details and to access through your institution.
Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision-making of oncology medicines.
- Published in:
- Pharmacology Research & Perspectives, 2021, v. 9, n. 2, p. 1, doi. 10.1002/prp2.742
- By:
- Publication type:
- Article
Real World Data in Health Technology Assessment of Complex Health Technologies.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.837302
- By:
- Publication type:
- Article
Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 6, p. 883, doi. 10.1007/s40258-019-00496-1
- By:
- Publication type:
- Article
Regulatory reliance pathways during health emergencies: enabling timely authorizations for COVID-19 vaccines in Latin America.
- Published in:
- Pan American Journal of Public Health, 2022, v. 46, p. 1, doi. 10.26633/RPSP.2022.115
- By:
- Publication type:
- Article
When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs.
- Published in:
- International Journal of Environmental Research & Public Health, 2023, v. 20, n. 1, p. 340, doi. 10.3390/ijerph20010340
- By:
- Publication type:
- Article
A novel method for predicting the budget impact of innovative medicines: validation study for oncolytics.
- Published in:
- European Journal of Health Economics, 2020, v. 21, n. 6, p. 845, doi. 10.1007/s10198-020-01176-x
- By:
- Publication type:
- Article
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group.
- Published in:
- International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S0266462323000375
- By:
- Publication type:
- Article
The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries’ past health technology assessments.
- Published in:
- International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S0266462323000338
- By:
- Publication type:
- Article
PP111 Reimbursement And Payment Models: A Survey Of Stakeholders' Current Experiences And Future Outlook Within The Dutch Policy Setting.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, p. S76, doi. 10.1017/S0266462322002343
- By:
- Publication type:
- Article
PP37 A Systematic Review of Machine Learning and Statistical Models For Predicting Coronary Heart Disease In Diabetic Patients.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, p. S52, doi. 10.1017/S0266462322001799
- By:
- Publication type:
- Article
OP89 The CE-Signal, A New Simplified Health Technology Assessment Method To Determine Whether Interventions Are Cost-Effective.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, p. S33, doi. 10.1017/S0266462322001350
- By:
- Publication type:
- Article
OP11 Differences And Similarities In Past Health Technology Assessments In Beneluxa Initiative Countries.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, p. S5, doi. 10.1017/S0266462322000708
- By:
- Publication type:
- Article
Understanding innovation of health technology assessment methods: the IHTAM framework.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, n. 1, p. 1, doi. 10.1017/S0266462322000010
- By:
- Publication type:
- Article
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, n. 1, p. 1, doi. 10.1017/S026646232100177X
- By:
- Publication type:
- Article
Understanding innovation of health technology assessment methods: the IHTAM framework.
- Published in:
- International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S0266462322000010
- By:
- Publication type:
- Article
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
- Published in:
- International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S026646232100177X
- By:
- Publication type:
- Article
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Getting the Right Evidence After Drug Approval.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.569535
- By:
- Publication type:
- Article
Efficacy gap between phase II and subsequent phase III studies in oncology.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 7, p. 1306, doi. 10.1111/bcp.14237
- By:
- Publication type:
- Article
Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 136, doi. 10.1002/cpt.3252
- By:
- Publication type:
- Article
Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 2, p. 350, doi. 10.1002/cpt.1835
- By:
- Publication type:
- Article
Weighing of Evidence by Health Technology Assessment Bodies: Retrospective Study of Reimbursement Recommendations for Conditionally Approved Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 3, p. 684, doi. 10.1002/cpt.1251
- By:
- Publication type:
- Article
Comment on "Deterministic Sensitivity Analysis Under Ignorance".
- Published in:
- 2021
- By:
- Publication type:
- Letter
The Application and Implications of Novel Deterministic Sensitivity Analysis Methods.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 1, p. 1, doi. 10.1007/s40273-020-00979-3
- By:
- Publication type:
- Article
Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis.
- Published in:
- International Journal of Environmental Research & Public Health, 2020, v. 17, n. 22, p. 8309, doi. 10.3390/ijerph17228309
- By:
- Publication type:
- Article
Synergy between health technology assessments and clinical guidelines for multiple sclerosis.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 5, p. 835, doi. 10.1111/cts.13492
- By:
- Publication type:
- Article
Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 4, p. 1566, doi. 10.1111/cts.13027
- By:
- Publication type:
- Article
The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs.
- Published in:
- International Journal of Health Policy & Management, 2022, v. 11, n. 5, p. 642, doi. 10.34172/ijhpm.2020.198
- By:
- Publication type:
- Article
Effects of alcohol hangover on simulated highway driving performance.
- Published in:
- Psychopharmacology, 2014, v. 231, n. 15, p. 2999, doi. 10.1007/s00213-014-3474-9
- By:
- Publication type:
- Article
Outlook for tuberculosis elimination in California: An individual-based stochastic model.
- Published in:
- PLoS ONE, 2019, v. 14, n. 4, p. 1, doi. 10.1371/journal.pone.0214532
- By:
- Publication type:
- Article
Regulatory reliance pathways during health emergencies: enabling timely authorizations for COVID-19 vaccines in Latin America.
- Published in:
- Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2022, v. 46, p. 1, doi. 10.26633/RPSP.2022.115
- By:
- Publication type:
- Article
Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study.
- Published in:
- Drug Safety, 2023, v. 46, n. 4, p. 357, doi. 10.1007/s40264-023-01279-3
- By:
- Publication type:
- Article
Do Health Technology Assessment organisations consider manufacturers' costs in relation to drug price? A study of reimbursement reports.
- Published in:
- Cost Effectiveness & Resource Allocation, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12962-022-00383-y
- By:
- Publication type:
- Article
Increasing the information provided by probabilistic sensitivity analysis: The relative density plot.
- Published in:
- Cost Effectiveness & Resource Allocation, 2020, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12962-020-00251-7
- By:
- Publication type:
- Article